489
Views
30
CrossRef citations to date
0
Altmetric
Reviews

Menopausal hot flushes revisited

&
Pages 3-15 | Received 19 May 2008, Accepted 15 Oct 2008, Published online: 03 Jul 2009

References

  • World Health Organisation Scientific Group. Menopause. WHO Technical Report Series, 866 1996; 7(4)236–242
  • Freedman R R. Physiology of hot flashes. Am J Hum Biol 2001; 13: 453–464
  • Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990; 592: 52–86
  • Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993; 307: 836–840
  • Oldenhave A, Netelenbos C. Pathogenesis of climacteric complaints: ready for the change?. Lancet 1994; 343: 649–653
  • Staropoli C A, Flaws J A, Bush T L, Moulton A W. Predictors of menopausal hot flashes. J Women's Health 1998; 7: 1149–1155
  • Stearns V, Ullmer L, Lopez J F, Smith Y, Isaacs C, Hayes D F. Hot flushes. Lancet 2002; 360: 1851–1861
  • Rödström K, Bengtsson C, Lissner L, Milsom I, Sundh V, Bjorkelund C. A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002; 9: 156–161
  • Deecher D C, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause and postmenopause life stages. Arch Womens Ment Health 2007; 10: 247–257
  • Thompson B, Hart S A, Durno D. Menopausal age and symptomatology in general practice. J Biosoc Sci 1973; 5: 71–82
  • McKinlay S M, Jeffreys M. The menopausal syndrome. Br J Prev Soc Med 1974; 28: 108–115
  • Williams R E, Kalilani L, Dibenedetti D B, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopasual women in the United States. Climacteric 2008; 11: 32–43
  • Jaszmann L, Lith N D, Zaat J CA. The perimenopausal symptoms: the statistical analysis of a survey. Med Gynaecol Sociol 1969; 4: 268–273
  • Freeman E W, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007; 10: 197–214
  • Gold E B, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of Women's Health Across the Nation. Am J Publ Health 2006; 96: 1226–1235
  • Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: the Japanese case. Maturitas 1988; 10: 317–332
  • Boulet M J, Oddens B J, Lehert P, Verner H M, Visser A. Climacteric and menopause in seven south-east Asian countries. Maturitas 1994; 19: 205–209
  • Ho S C, Chan S G, Yip Y B, Cheng A, Yi Q, Chan C. Menopausal symptoms and symptom clustering in Chinese women. Maturitas 1999; 33: 219–227
  • Chim H, Tan B H, Ang C C, Chew E M, Chong Y S, Saw S M. The prevalence of menopausal symptoms in a community in Singapore. Maturitas 2002; 41: 275–282
  • Haines C J, Xing S M, Park K H, Holinka C F, Ausmanas M K. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated oestrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Maturitas 2005; 52: 264–276
  • Hahn P M, Wong J, Reid R L. Menopausal-like hot flushes reported in women of reproductive age. Fertil Steril 1998; 70: 913–918
  • Guthrie J R, Dennerstein L, Hopper J L, Burger H G. Hot flushes, menstrual status and hormone levels in a population-based sample of midlife women. Obstet Gynecol 1996; 88: 437–442
  • Gold E B, Sternfeld B, Kelsey J L, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 2000; 152: 463–473
  • Avis N E, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001; 52: 345–356
  • Grisso J A, Freeman E W, Maurin E, Garcia-Espana B, Berlin J A. Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med 1999; 14: 98–103
  • Miller S R, Gallicchio L M, Lewis L M, et al. Association between race and hot flashes in midlife women. Maturitas 2006; 54: 260–269
  • Schwingl P J, Hulka B S, Harlow S D. Risk factors for menopausal hot flashes. Obstet Gynecol 1994; 84: 29–34
  • Gerber L M, Sievert L L, Warren K, Pickering T G, Schwartz J E. Hot flushes are associated with increased ambulatory systolic blood pressure. Menopause 2007; 14: 308–315
  • Dennerstein L, Smith A M, Morse C, et al. Menopausal symptoms in Australian women. Med J Aust 1993; 159: 232–236
  • Avis N E, Crawford S L, McKinlay S M. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 1997; 3: 103–120
  • Freeman E W, Sammel M D, Grisso J A, Battistine M, Garcia-Espagna B, Hollander L. Hot flashes in the late reproductive years: risk factors for African American and Caucasian women. J Women's Health 2001; 10: 67–76
  • Whiteman M K, Staropoli C, Langenberg P, McCarter R, Kjerulff K, Flaws J A. Smoking, body mass and hot flushes in mid-life women. Obstet Gynecol 2003; 101: 264–272
  • Van Keep P A, Kellerhals J M. The impact of socio-cultural factors on symptom formation. Some results of a study on ageing women in Switzerland. Psychother Psychosom 1974; 23: 251–263
  • Flint M P. Sociology and anthropology of the menopause. Female and Male Climacteric, P A Van Keep, D M Serr, R B Greenblatt. MTP Press, Lancaster 1979
  • Ginsburg J, Swinhoe J, O'Reilly B. Cardiovascular responses during the menopausal hot flush. Br J Obstet Gynaecol 1981; 88: 925–930
  • Thurston R C, Blumenthal J A, Babyak M A, Sherwood A. Emotional antecedents of hot flushes during daily life. Psychosom Med 2005; 67: 137–146
  • Joffe H, Hall J E, Soares C N, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002; 9: 392–398
  • Avis N E, Crawford S, Stellato R, Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001; 4: 243–249
  • Freeman E W, Sammel M D, Lin H, Gracia C, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 2005; 12: 258–266
  • Sturdee D W, Reece B L. Thermography of menopausal hot flushes. Maturitas 1979; 1: 201–205
  • Cignarelli M, Cicinelli E, Corso M, et al. Biophysical and endocrine-metabolic changes during menopausal hot flashes: increase in plasma free fatty acid and norepinephrine levels. Gynecol Obstet Invest 1989; 27: 34–37
  • De Bakker I P, Everaerd W. Measurement of menopausal hot flushes: validation and cross-validation. Maturitas 1996; 25: 87–98
  • Freedman R R, Woodward S, Mayes M M. Nonneural mediation of digital vasodilation during menopausal hot flushes. Gynecol Obstet Invest 1994; 38: 206–209
  • Wilkin J K. Why is flushing limited to a mostly facial cutaneous distribution?. J Am Acad Dermatol 1988; 19: 309–313
  • Freedman R R. Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 1989; 26: 573–579
  • Freedman R R, Norton D, Woodward S, Cornélissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995; 80: 2354–2358
  • Carpenter J S, Andrykowski M A, Freedman R R, Munn R. Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause 1999; 6: 209–215
  • Silverman R W, Bajorek J G, Lomax P, Tataryn I V. Monitoring the pathophysiological correlates of post-menopausal hot flushes. Maturitas 1981; 3: 39–46
  • Freedman R R, Wasson S. Miniature hygrometric hot flash recorder. Fertil Steril 2007; 88: 494–496
  • Kerslake D M, Cooper K E. Vasodilation in the hand in response to heating the skin elsewhere. Clin Sci 1950; 9: 31–47
  • Barcroft H, Bonnar W M, Edholm O G. Reflex vasodilation in human skeletal muscle in response to heating the body. J Physiol (Lond) 1947; 106: 271–278
  • Ginsburg J, Hardiman P, O'Reilly B. Peripheral blood flow in menopausal women who have hot flushes and in those who do not. Br Med J 1989; 298: 1488–1490
  • Freedman R R, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 1999; 181: 66–70
  • Boulant J A. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 2000; 31(Suppl 5)S157–S161
  • Romanovsky A A. Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system. Am J Physiol Regul Integr Comp Physiol 2007; 292: R37–R46
  • Freedman R R, Benton M D, Genik R J, 2nd, Graydon F X. Cortical activation during menopausal hot flashes. Fertil Steril 2006; 85: 674–678
  • Shanafelt T D, Barton D L, Adjei A A, Loprinzi C L. Pathophysiology and treatment of hot flashes. Mayo Clin Proc 2002; 77: 1207–1218
  • Berendsen H HG. The role of serotonin in hot flushes. Maturitas 2000; 36: 155–164
  • Brick J F. Hot flush epilepsy. South Med J 1988; 81: 88–91
  • Genazzani A R, Gambacciani M, Simoncini T, Schneider H PG. Hormone replacement therapy in climacteric and aging brain. Position Paper from the International Menopause Society Expert Workshop, Pisa, Italy, 15–18 March 2003. Climacteric 2003; 6: 188–203
  • Freedman R R, Woodward S, Sabharwal S C. α2-Adrenergic mechanism in menopausal hot flashes. Obstet Gynecol 1990; 76: 573–578
  • Freedman R R, Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertil Steril 2000; 74: 20–23
  • Clayden J R, Bell J W, Pollard P. Menopausal flushing: double-blind trial of a non-hormonal medication. BMJ 1974; 1: 409–412
  • Nelson H D, Vesco K, Haney E. Clonidine, gabapentin and some SSRIs effective for hot flashes. J Fam Pract 2006; 55: 662
  • Guttuso T, Jr, Kurlan R, McDermott M P, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003; 101: 337–345
  • Pandya K J, Morrow G R, Roscoe J A, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomized double-blind placebo-controlled trial. Lancet 2005; 366: 818–824
  • Loprinzi C L, Kugler J W, Barton D L, et al. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol 2007; 25: 308–312
  • Butt D A, Lock M, Lewis J E, Ross S, Moineddin R. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Menopause 2008; 15: 310–318
  • Slopien R, Meczekalski B, Warenik-Szymankiewicz A. Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women. Climacteric 2003; 6: 53–57
  • Stearns V, Loprinzi C L. New therapeutic approaches for hot flashes in women. J Support Oncol 2003; 1: 11–21
  • Deecher D C, Alfinito P D, Leventhal L, et al. Alleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlaflaxine succinate in ovariectomized rodent models. Endocrinology 2007; 148: 1376–1383
  • Øverlie I, Moen M H, Holte A, Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 2002; 41: 69–77
  • Randolph J F, Jr, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005; 90: 6106–6112
  • Randolph J F, Jr, Sowers M F, Bondarenko I V, Harlow S D, Luborsky J L, Little R J. Change in oestradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004; 89: 1555–1561
  • Holte A. Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas 1992; 14: 127–141
  • Dennerstein L, Dudley E C, Hopper J L, Guthrie J R, Burger H G. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000; 96: 351–358
  • Naessen T, Persson I, Ljunghall S, Bergstrom R. Women with climacteric symptoms: a target group for prevention of rapid bone loss and osteoporosis. Osteoporos Int 1992; 2: 225–231
  • Woods N F, Mitchell E S, Tao Y, Viernes H M, Stapleton P L, Farin F M. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study. Menopause 2006; 13: 902–910
  • Schilling C, Gallicchio L, Miller S R, Langenberg P, Zacur H, Flaws J A. Genetic polymorphisms, hormone levels and hot flashes in midlife women. Maturitas 2007; 57: 120–131
  • Casper R F, Yen S SC. Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism. Clin Endocrinol (Oxf) 1985; 22: 293–312
  • Hendrix S L. Bilateral oophorectomy and premature menopause. Am J Med 2005; 118(Suppl 12B)131–135
  • Mom C H, Buijs C, Willemse P H, Mourits M J, de Vries E G. Hot flushes in breast cancer patients. Crit Rev Oncol Haematol 2006; 57: 63–77
  • Feldman J M, Postlethwaite R W, Glenn J F. Hot flushes and sweats in men with testicular insufficiency. Arch Intern Med 1976; 136: 606–608
  • Steinfeld A D, Reinhardt C. Male climacteric after orchidectomy in patient with prostatic cancer. Urology 1980; 16: 620–622
  • Linde R, Doelle G C, Alexander N, et al. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. N Engl J Med 1981; 305: 663–667
  • Casper R F, Yen S SC, Wilkes M M. Menopausal flushes: a neuroendocrine link with pulsatile luteinizing hormone secretion. Science 1979; 205: 823–825
  • Tataryn I V, Meldrum D R, Lu K H, Frumar A M, Judd H L. LH, FSH and skin temperature during the menopausal hot flush. J Clin Endocrinol Metab 1979; 49: 152–154
  • Casper R F, Yen S SC. Menopausal flushes: effect of pituitary gonadotrophin desensitization by a potent luteinizing hormone-releasing factor agonist. J Clin Endocrinol Metab 1981; 53: 1056–1058
  • DeFazio J, Meldrum D R, Laufer L, et al. Induction of hot flushes in premenopausal women treated with a long-acting GnRH agonist. J Clin Endocrinol Metab 1983; 56: 445–448
  • Erlik Y, Meldrum D R, Judd H L. Estrogen levels in postmenopausal women with hot flushes. Obstet Gynecol 1982; 59: 403–407
  • Ryan K J, Berkowitz R S, Barbieri R V, Dunaif A. Kistner's Gynaecology and Women's Health7th edn. Mosby, St Louis 1999
  • Den Tonkelaar I, Seidell J C, van Noord P A. Obesity and fat distribution in relation to hot flashes in Dutch women from the DOM-project. Maturitas 1996; 23: 301–305
  • Freedman R R. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 2005; 23: 117–125
  • Thurston R C, Sowers M R, Sutton-Tyrell K, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008; 15: 429–434
  • Anderson G S. Human morphology and temperature regulation. Int J Biometeorol 1999; 43: 99–109
  • Hormone-replacement therapy: safety update. UK Public Assessment Report, MHRA, September 2007, http://www.mhra. gov.uk/
  • MacLennan A H, Broadbent J L, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004, 4, CD002978
  • Nelson H D. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 2004; 291: 1610–1620
  • Good W R, John V A, Ramirez M, Higgins J E. Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Climacteric 1999; 2: 29–36
  • Kocjan T, Prelevic G M. Hormone replacement therapy update: who should we be prescribing this to now?. Curr Opin Obstet Gynecol 2003; 15: 459–464
  • Stephenson J. FDA orders estrogen safety warnings: agency offers guidance for HRT use. JAMA 2003; 289: 537–538
  • Wyeth Pharmaceuticals website. Available at http://www.prempro.com Accessed May 2008
  • Utian W H, Shoupe D, Bachmann G, Pinkerton J V, Pickar J H. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001; 75: 1065–1079
  • Gambacciani M, Ciaponi M, Cappagli B, et al. Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy. Maturitas 2003; 45: 175–183
  • Ettinger B. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage. Am J Med 2005; 118(Suppl 2)74–78
  • Panay N, Ylikorkala O, Archer D F, Gut R, Lang E. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric 2007; 10: 120–131
  • Grady D, Sawaya G F. Discontinuation of postmenopausal hormone therapy. Am J Med 2005; 118(Suppl 2)163–165
  • Grady D, Wenger N K, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000; 132: 689–696
  • Seibel M M. Treating hot flushes without hormone replacement therapy. J Fam Pract 2003; 52: 291–296
  • Rossouw J E, Anderson G L, Prentice R L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
  • Bakken K, Eggen A E, Lund E. Side-effects of hormone replacement therapy and influence in pattern of use among women aged 45–64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstet Gynecol Scand 2004; 83: 850–856
  • Bjorn I, Backstrom T. Drug related negative side-effects are a common reason for poor compliance in hormone replacement therapy. Maturitas 1999; 32: 77–86
  • Newton K M, Buist D S, Keenan N L, Anderson L A, LaCroix A Z. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 2002; 100: 18–25
  • Hammar M, Christau S, Nathorst-Böös J, Rud T, Garre K. A double-blind, randomized trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998; 105: 904–911
  • Egarter C, Huber J, Leikermoser R, et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas 1996; 23: 55–62
  • Laan E, Van Lunsen R HW, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001; 4: 28–41
  • Lippuner K, Haenggi W, Birkhaeuser M H, Casez J P, Jaeger P. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone. J Bone Miner Res 1997; 12: 806–812
  • Cummings S R, Ettinger B, Delmas P D, et al. for the LIFT Trial Investigators. The effects of tibolone in older postmenopausal women. N Engl J Med 2008; 359: 697–708
  • Schiff I, Tulchinsky D, Cramer D, Ryan K J. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA 1980; 244: 1443–1445
  • Loprinzi C L, Michalak J C, Quella S K, O'Fallon J R, Hatfield A K, Nelimark R A. Mergestrol acetate for the prevention of hot flushes. N Engl J Med 1994; 331: 347–352
  • Leonetti H B, Longo S, Anasti J N. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999; 94: 225–228
  • Komesaroff P A, Black C V, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001; 4: 144–150
  • Freedman R R. Current best treatment for hot flashes. Menopause Management 2006; 15: 20–25
  • Stearns V, Beebe K L, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopause hot flashes: a randomized controlled trial. JAMA 2003; 289: 2827–2834
  • Stearns V, Slack R, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005; 23: 6919–6930
  • Loprinzi C L, Kugler J W, Sloan J A, et al. Venlaflaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000; 356: 2059–2063
  • Evans M L, Pritts E, Vittinghoff E, McClish K, Morgan K S, Jaffe R B. Management of postmenopausal hot flushes with venlaflaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005; 105: 161–166
  • Albertazzi P. Non-estrogenic approaches for the treatment of climacteric symptoms. Climacteric 2007; 10(Suppl 2)115–120
  • Gordon P R, Kerwin J P, Boesen K G, Senf J. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population. Menopause 2006; 13: 546–548
  • Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al. Citalopram and fluoxetine in the treatment of post-menopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005; 12: 18–26
  • Loprinzi C L, Flynn P J, Carpenter L A, et al. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlaflaxine. J Palliat Med 2005; 8: 924–930
  • Reddy S Y, Warner H, Guttuso T, Jr, et al. Gabapentin, estrogen and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 2006; 108: 41–48
  • Goldberg R M, Loprinzi C L, O'Fallon J R, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 1994; 12: 155–158
  • Pandya K J, Raubertas R F, Flynn P J, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 2000; 132: 788–793
  • Sack M N, Rader D J, Cannon RO I II. Oestrogen and inhibition of oxidation of low-density lipoprotein in postmenopausal women. Lancet 1994; 343: 269–270
  • Tranquilli A L, Mazzanti L, Cugini A M, Cester N, Garzeti G G, Romanini C. Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidant. Gynecol Endocrinol 1995; 9: 137–141
  • Meydany M. Vitamin E. Lancet 1995; 345: 170–175
  • Christy C. Vitamin E in menopause. Am J Obstet Gynecol 1945; 50: 84–87
  • McLaren H. Vitamin E in menopause. BMJ 1949; 2: 1378–1381
  • Barton D L, Loprinzi C L, Quella S K, et al. Prospective evaluation of vitamin E for hot flushes in breast cancer survivors. J Clin Oncol 1998; 16: 495–500
  • Knight D C, Eden J A. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996; 87: 897–904
  • Thompson L U, Robb P, Serraino M. Mammalian lignan production from various foods. Nutr Canc 1991; 16: 43–52
  • Murkies A L, Wilcox G, Davis S R. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab 1998; 83: 297–303
  • Cassidy A, Bingham S, Carlson J, Setchell K DR. Biological effects of plant estrogens in premenopausal women. FASEB J 1993; A: 866
  • Cassidy A, Bingham S, Setchell K DR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60: 333–340
  • Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 1993; 45: 399–405
  • Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol 2001; 153: 790–793
  • Williamson-Hughes P S, Flickinger B D, Messina M J, Empie M W. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause 2006; 13: 831–839
  • Cheng G, Wilczek B, Warner M, Gustafsson J A, Landgren B M. Isoflavone treatment for acute menopausal symptoms. Menopause 2007; 14: 468–473
  • D'Anna R, Cannata M L, Atteritano M, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause 2007; 14: 648–655
  • Sievert L L, Morrison L, Brown D E, Reza A M. Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii. Menopause 2007; 14: 261–269
  • Booth N L, Piersen C E, Banuvar S, Geller S E, Shulman L P, Farnworth N R. Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review. Menopause 2006; 13: 251–264
  • Tice J A, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings S R. Phytoestrogen supplements for the treatment of hot flashes: The Isoflavone Clover Extract (ICE) Study. A randomized controlled trial. JAMA 2003; 290: 207–214
  • Struck D, Tegtmeier M, Harnishfeger G. Flavones in extracts of Cimicifuga racemosa. Planta Med 1997; 63: 289–290
  • Jacobson J S, Troxel A B, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001; 19: 2739–2745
  • Newton K M, Reed S D, LaCroix A Z, Grothaus L C, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006; 145: 869–879
  • Page R L, 2nd, Lawrence J D. Potentiation of warfarin by dong quai. Pharmacotherapy 1999; 19: 870–876
  • Chenoy R, Hussain S, Tayob Y, O'Brien P MS, Moss M Y, Morse P F. Effect of oral gamalenic acid from evening primrose oil on menopausal flushing. BMJ 1994; 308: 501–503
  • Mahady G B, Low Dog T, Barrett M L, et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15: 628–638
  • Joy D, Joy J, Duane P. Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric Feb, 2008; 11(1)84–88
  • Chow E C, Teo M, Ring J A, Chen J W. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust Apr 7, 2008; 188(7)420–422
  • Hirata J D, Swiers L M, Zell B, Small R, Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind placebo-controlled trial. Fertil Steril 1997; 68: 981–986
  • Zaborowska E, Brynhildsen J, Damberg S, et al. Effects of acupuncture, applied relaxation, estrogens and placebo on hot flushes in postmenopausal women: an analysis of two prospective, parallel, randomized studies. Climacteric 2007; 10: 38–45
  • Huang M I, Nir Y, Chen B, Schnyer R, Manber R. A randomized controlled pilot study of acupuncture for postmenopausal hot flashes: effect on nocturnal hot flashes and sleep quality. Fertil Steril 2006; 86: 700–710
  • Vincent A, Barton D L, Mandrekar J N, et al. Acupuncture for hot flashes: a randomized, sham-controlled clinical study. Menopause 2007; 14: 45–52
  • Carpenter J S, Neal J G. Other complementary and alternative medicine modalities: acupuncture, magnets, reflexology and homeopathy. Am J Med 2005; 118(Suppl 12B)109–117
  • Nedrow A, Miller J, Walker M, Nygren P, Huffmann L H, Nelson H D. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006; 166: 1453–1465
  • The North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004; 11: 11–33
  • Daley A, Stokes-Lampard H, Mutrie N, MacArthur C. Exercise for vasomotor symptoms. Cochrane Database of Systematic Reviews 2007, Issue 4. Art No CD006108. DOI:10.1002/14651858. CD006108.pub2
  • Guthrie J R, Dennerstein L, Taffe J R, Lehert P, Burger H G. Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause 2005; 12: 460–467
  • Greendale G A, Gold E B. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?. Am J Med 2005; 118(Suppl 12B)148–154
  • Grady D. Management of menopausal symptoms. N Engl J Med 2006; 355: 2338–2347
  • Freedman R R, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992; 167: 436–439
  • Nelson H D, Vesco K K, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006; 295: 2057–2071
  • Lethaby A E, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms, Cochrane Database of Systematic Reviews 2007, Issue 4. Art No CD001395. DOI:10.1002/14651858. CD001395.pub3
  • Krebbs E E, Ensrud K E, MacDonald R, Wilt T J. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004; 104: 824–836

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.